TW216442B - Pressurised aerosol compositions - Google Patents

Pressurised aerosol compositions

Info

Publication number: TW216442B
Authority: TW; Taiwan
Prior art keywords: pressurised aerosol; units; aerosol compositions; liquefied hydrofluoroalkane; containing units
Prior art date: 1991-09-25

Application number

TW081107686A

Other languages

English (en)

Inventor

Nagarbhai Mistry Suresh

Gibson Mark

Original Assignee

Fisons Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-25

Filing date

1992-09-29

Publication date

1993-11-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27450754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW216442(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-09-25 Priority claimed from GB919120396A external-priority patent/GB9120396D0/en

1991-09-28 Priority claimed from GB919120675A external-priority patent/GB9120675D0/en

1991-11-19 Priority claimed from GB919124661A external-priority patent/GB9124661D0/en

1992-02-14 Priority claimed from GB929203212A external-priority patent/GB9203212D0/en

1992-09-29 Application filed by Fisons Plc filed Critical Fisons Plc

1993-11-21 Application granted granted Critical

1993-11-21 Publication of TW216442B publication Critical patent/TW216442B/zh

Links

239000000443 aerosol Substances 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
150000005828 hydrofluoroalkanes Chemical class 0.000 abstract 2
229920000642 polymer Polymers 0.000 abstract 2
150000001408 amides Chemical class 0.000 abstract 1
125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Otolaryngology (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Colloid Chemistry (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

TW081107686A 1991-09-25 1992-09-29 Pressurised aerosol compositions TW216442B (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB919120396A GB9120396D0 (en)	1991-09-25	1991-09-25	Formulations
GB919120675A GB9120675D0 (en)	1991-09-28	1991-09-28	Formulation
GB919124661A GB9124661D0 (en)	1991-11-19	1991-11-19	Formulations
GB929203212A GB9203212D0 (en)	1992-02-14	1992-02-14	Pharmaceutical formulations
PCT/GB1992/001749 WO1993005765A1 (en)	1991-09-25	1992-09-23	Pressurised aerosol compositions

Publications (1)

Publication Number	Publication Date
TW216442B true TW216442B (en)	1993-11-21

Family

ID=27450754

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW081107686A TW216442B (en)	1991-09-25	1992-09-29	Pressurised aerosol compositions

Country Status (28)

Country	Link
US (1)	US6641800B1 (zh)
EP (2)	EP0534731A1 (zh)
JP (1)	JP3142136B2 (zh)
KR (1)	KR100275426B1 (zh)
CN (1)	CN1050285C (zh)
AT (1)	ATE132739T1 (zh)
AU (1)	AU654397B2 (zh)
BG (1)	BG61752B1 (zh)
BR (1)	BR9206549A (zh)
CA (1)	CA2119932C (zh)
CZ (1)	CZ282506B6 (zh)
DE (1)	DE69207606T3 (zh)
DK (1)	DK0605578T4 (zh)
ES (1)	ES2082507T5 (zh)
FI (1)	FI110407B (zh)
GR (2)	GR3019098T3 (zh)
HU (2)	HUT67480A (zh)
IL (1)	IL103238A (zh)
MX (1)	MX9205483A (zh)
MY (1)	MY108309A (zh)
NO (1)	NO307124B1 (zh)
NZ (1)	NZ244439A (zh)
RO (1)	RO114735B1 (zh)
RU (1)	RU2122852C1 (zh)
SK (1)	SK279456B6 (zh)
TW (1)	TW216442B (zh)
UA (1)	UA41873C2 (zh)
WO (1)	WO1993005765A1 (zh)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
GB9214819D0 (en) *	1992-07-13	1992-08-26	Minnesota Mining & Mfg	Valve assemblies
KR100321649B1 (ko) *	1993-03-17	2002-07-22	미네소타 마이닝 앤드 매뉴팩춰링 캄파니	에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
US6042811A (en) *	1993-03-17	2000-03-28	3M Innovative Properties Company	Aerosol formulation containing a diol-diacid derived dispersing aid
CN1086575C (zh)	1995-06-27	2002-06-26	贝林格尔·英格海姆公司	用于制备无推进气体的雾剂的新颖稳定药物组合物
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
US6039932A (en) *	1996-09-27	2000-03-21	3M Innovative Properties Company	Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) *	1997-02-07	2000-10-03	3M Innovative Properties Company	Biocompatible compounds for pharmaceutical drug delivery systems
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en)	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6946117B1 (en)	1997-09-29	2005-09-20	Nektar Therapeutics	Stabilized preparations for use in nebulizers
US6433040B1 (en)	1997-09-29	2002-08-13	Inhale Therapeutic Systems, Inc.	Stabilized bioactive preparations and methods of use
US6309623B1 (en)	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US6451285B2 (en) *	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6136294C1 (en) *	1998-09-22	2002-09-24	Aeropharm Technology Inc	Amino acid stabilized medical aerosol formulation
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6540982B1 (en) *	2000-01-25	2003-04-01	Aeropharm Technology Incorporated	Medical aerosol formulation
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US20030026766A1 (en) *	2000-04-13	2003-02-06	Mark Sanders	Medicaments for treating respiratory disorders comprising formoterol and fluticasone
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt)	2000-05-10	2014-12-16	Novartis Ag	Pós à base de fosfolípidos para administração de fármacos
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU5070100A (en)	2000-05-22	2001-12-03	Chiesi Farma Spa	Stable pharmaceutical solution formulations for pressurised metered dose inhalers
SI1273292T1 (en)	2001-07-02	2004-12-31	Chiesi Farmaceutici S.P.A.	Optimised formulation of tobramycin for aerosolization
GB0208742D0 (en)	2002-04-17	2002-05-29	Bradford Particle Design Ltd	Particulate materials
TWI324518B (en)	2001-12-19	2010-05-11	Nektar Therapeutics	Pulmonary delivery of aminoglycosides
US7544177B2 (en) *	2002-01-24	2009-06-09	The Regents Of The University Of California	Aerosol device to deliver bioactive agent
SE0200312D0 (sv) *	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
US7582284B2 (en)	2002-04-17	2009-09-01	Nektar Therapeutics	Particulate materials
US7244742B2 (en) *	2002-08-17	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co Kg	Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
GB0328630D0 (en) *	2003-12-10	2004-01-14	Medpharm Ltd	Metered dose inhalation preparations
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CA2559208A1 (en) *	2004-03-17	2005-09-29	Mpex Pharmaceuticals, Inc.	Use and administration of bacterial efflux pump inhibitors
US7994225B2 (en) *	2004-03-17	2011-08-09	Rempex Pharmaceuticals, Inc.	Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
US20070031343A1 (en) *	2005-08-04	2007-02-08	Bonfour Charles A Iii	Flavored medicinal inhalant
FR2895260B1 (fr) *	2005-12-23	2009-02-20	Servier Lab	Nouvelle composition pharmaceutique a base d'huile essentielle pour pulverisation nasale et/ou buccale
DE102006017320A1 (de) *	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
KR20150041804A (ko)	2007-02-11	2015-04-17	맵 파마슈티컬스, 인코포레이티드	부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법
WO2008152398A2 (en) *	2007-06-14	2008-12-18	Cipla Limited	Formulations for inhalation
GB0712454D0 (en)	2007-06-27	2007-08-08	Generics Uk Ltd	Pharmaceutical compositions
JP2011519679A (ja)	2008-05-06	2011-07-14	ウィルソン−クック・メディカル・インコーポレーテッド	治療薬を送達するための器具及び方法
RU2565438C2 (ru) *	2008-11-04	2015-10-20	Сипла Лимитед	Фармацевтическая аэрозольная композиция
WO2010074949A1 (en)	2008-12-23	2010-07-01	Wilson-Cook Medical Inc.	Apparatus and methods for containing and delivering therapeutic agents
US9101744B2 (en)	2009-05-29	2015-08-11	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
US8118777B2 (en)	2009-05-29	2012-02-21	Cook Medical Technologies Llc	Systems and methods for delivering therapeutic agents
CN102416179B (zh)	2010-09-28	2014-05-07	益得生物科技股份有限公司	用于哮喘的吸入性复方组合物
US11931227B2 (en)	2013-03-15	2024-03-19	Cook Medical Technologies Llc	Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9867931B2 (en)	2013-10-02	2018-01-16	Cook Medical Technologies Llc	Therapeutic agents for delivery using a catheter and pressure source
GB201402513D0 (en) *	2014-02-13	2014-04-02	Cardiff Scintigraphics Ltd	Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en)	2014-07-29	2017-07-06	3M Innovative Properties Company	Method of preparing a pharmaceutical composition
BR112018006406B1 (pt) *	2015-10-23	2022-01-18	Basf Se	Formulação odorante e aromatizante, e, uso de uma formulação
US10702495B2 (en)	2017-02-20	2020-07-07	Nexien Biopharma, Inc.	Method and compositions for treating dystrophies and myotonia
EP3750528A1 (en)	2019-06-11	2020-12-16	Nexien Biopharma, Inc.	Compositions for treating dystrophies and myotonia
KR20230002873A (ko)	2020-06-05	2023-01-05	쿡 메디컬 테크놀러지스 엘엘씨	치료제 전달을 위한 의료용 스코프

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US417295A (en) *		1889-12-17		Fabriken
AT274245B (de)	1967-05-17	1969-09-10		Verfahren zur Herstellung eines Spezialklebers für Verbandmaterialien
US4025635A (en)	1972-09-06	1977-05-24	Burroughs Wellcome Co.	Cyclic sulphur compounds
CA1136547A (en) *	1979-03-08	1982-11-30	Song-Ling Lin	Aerosol anesthetic compositions
EP0175671A1 (de)	1984-08-23	1986-03-26	Kuhlemann & Co.	Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
CA1293929C (en) *	1986-03-10	1992-01-07	Kurt Burghart	Pharmaceutical composition containing nifedipine
EP0259383B1 (de)	1986-03-10	1991-01-23	Kurt Dr. Burghart	Pharmazeutikum sowie verfahren zu seiner herstellung
US4752466A (en)	1987-08-31	1988-06-21	Johnson & Johnson Products, Inc.	Thrombin aerosol
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
US5225183A (en)	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
GB8921222D0 (en)	1989-09-20	1989-11-08	Riker Laboratories Inc	Medicinal aerosol formulations
IL95952A0 (en)	1989-10-19	1991-07-18	Sterling Drug Inc	Aerosol composition for topical medicament
IE67185B1 (en)	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
US6123924A (en) *	1991-09-25	2000-09-26	Fisons Plc	Pressurized aerosol inhalation compositions
US5658549A (en)	1991-12-12	1997-08-19	Glaxo Group Limited	Aerosol formulations containing propellant 134a and fluticasone propionate
US5874064A (en) *	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery

1992
- 1992-09-22 IL IL10323892A patent/IL103238A/en not_active IP Right Cessation
- 1992-09-22 NZ NZ244439A patent/NZ244439A/en not_active IP Right Cessation
- 1992-09-23 BR BR9206549A patent/BR9206549A/pt not_active Application Discontinuation
- 1992-09-23 DK DK92920611T patent/DK0605578T4/da active
- 1992-09-23 SK SK340-94A patent/SK279456B6/sk not_active IP Right Cessation
- 1992-09-23 HU HU9400853A patent/HUT67480A/hu unknown
- 1992-09-23 AT AT92920611T patent/ATE132739T1/de active
- 1992-09-23 CA CA002119932A patent/CA2119932C/en not_active Expired - Lifetime
- 1992-09-23 ES ES92920611T patent/ES2082507T5/es not_active Expired - Lifetime
- 1992-09-23 WO PCT/GB1992/001749 patent/WO1993005765A1/en active IP Right Grant
- 1992-09-23 RO RO94-00492A patent/RO114735B1/ro unknown
- 1992-09-23 EP EP92308657A patent/EP0534731A1/en active Pending
- 1992-09-23 AU AU26471/92A patent/AU654397B2/en not_active Expired
- 1992-09-23 KR KR1019940700969A patent/KR100275426B1/ko not_active Expired - Lifetime
- 1992-09-23 MY MYPI92001697A patent/MY108309A/en unknown
- 1992-09-23 RU RU94022269/14A patent/RU2122852C1/ru active
- 1992-09-23 DE DE69207606T patent/DE69207606T3/de not_active Expired - Lifetime
- 1992-09-23 JP JP05505930A patent/JP3142136B2/ja not_active Expired - Fee Related
- 1992-09-23 EP EP92920611A patent/EP0605578B2/en not_active Expired - Lifetime
- 1992-09-23 UA UA94005331A patent/UA41873C2/uk unknown
- 1992-09-23 CZ CZ94695A patent/CZ282506B6/cs not_active IP Right Cessation
- 1992-09-25 MX MX9205483A patent/MX9205483A/es unknown
- 1992-09-25 CN CN92112491A patent/CN1050285C/zh not_active Expired - Lifetime
- 1992-09-29 TW TW081107686A patent/TW216442B/zh not_active IP Right Cessation
1994
- 1994-03-24 NO NO941077A patent/NO307124B1/no not_active IP Right Cessation
- 1994-03-24 BG BG98681A patent/BG61752B1/bg unknown
- 1994-03-25 FI FI941388A patent/FI110407B/fi not_active IP Right Cessation
1995
- 1995-03-20 HU HU95P/P00090P patent/HU210818A9/hu unknown
1996
- 1996-02-23 GR GR960400518T patent/GR3019098T3/el unknown
1999
- 1999-12-10 GR GR990403193T patent/GR3032103T3/el unknown
2000
- 2000-07-13 US US09/616,069 patent/US6641800B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9206549A (pt)	1995-10-17
MX9205483A (es)	1993-05-01
ATE132739T1 (de)	1996-01-15
NO307124B1 (no)	2000-02-14
HU9400853D0 (en)	1994-06-28
DK0605578T4 (da)	2000-03-06
ES2082507T3 (es)	1996-03-16
DE69207606T2 (de)	1996-06-27
BG61752B1 (bg)	1998-05-29
DE69207606T3 (de)	2000-03-16
FI941388L (fi)	1994-03-25
DE69207606D1 (de)	1996-02-22
WO1993005765A1 (en)	1993-04-01
CA2119932A1 (en)	1993-04-01
CZ282506B6 (cs)	1997-07-16
CZ69594A3 (en)	1995-11-15
HU210818A9 (en)	1995-08-28
CN1050285C (zh)	2000-03-15
RO114735B1 (ro)	1999-07-30
CN1071832A (zh)	1993-05-12
CA2119932C (en)	2002-05-21
EP0605578A1 (en)	1994-07-13
MY108309A (en)	1996-09-30
IL103238A0 (en)	1993-02-21
NZ244439A (en)	1994-01-26
UA41873C2 (uk)	2001-10-15
NO941077D0 (no)	1994-03-24
KR100275426B1 (ko)	2001-03-02
BG98681A (bg)	1995-02-28
EP0534731A1 (en)	1993-03-31
DK0605578T3 (da)	1996-03-25
HK1005564A1 (zh)	1999-01-15
SK279456B6 (sk)	1998-11-04
EP0605578B2 (en)	1999-09-22
HUT67480A (en)	1995-04-28
AU2647192A (en)	1993-04-27
JP3142136B2 (ja)	2001-03-07
RU2122852C1 (ru)	1998-12-10
AU654397B2 (en)	1994-11-03
ES2082507T5 (es)	1999-11-16
US6641800B1 (en)	2003-11-04
FI941388A0 (fi)	1994-03-25
NO941077L (no)	1994-05-18
SK34094A3 (en)	1994-11-09
FI110407B (fi)	2003-01-31
IL103238A (en)	1995-07-31
EP0605578B1 (en)	1996-01-10
GR3032103T3 (en)	2000-03-31
GR3019098T3 (en)	1996-05-31
JPH07502262A (ja)	1995-03-09

Legal Events

Date	Code	Title	Description
2012-11-11	MK4A	Expiration of patent term of an invention patent

Publication	Publication Date	Title
TW216442B (en)	1993-11-21	Pressurised aerosol compositions
BG102689A (en)	1999-02-26	Pharmaceutical aerosol composition
ZA94819B (en)	1995-08-07	Aerosol delivery apparatus
EP0647133A4 (en)	1997-10-29	COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY.
EP0701457A4 (en)	1997-12-17	SYSTEMS FOR INTERPULMONARY ADMINISTRATION OF AQUEOUS SOLUTIONS
CA2142126A1 (en)	1994-03-03	Inhalation powder containing antistatic agent
HUP9903916A3 (en)	2001-06-28	Phosphinic acid amides and pharmaceutical compositions containing the same
IL117706A0 (en)	1996-07-23	Powdered drug storage and delivery system
HUT70211A (en)	1995-09-28	Proteinoid carriers and methods for preparation and use thereof
ZA926019B (en)	1993-03-10	Pharmaceutical spheroid formulation.
EP0674528A4 (en)	1996-06-26	DRUG DELIVERY SYSTEM BASED ON CYCLODEXTRIN AND A POLYMER.
AU1162892A (en)	1992-08-27	Metered dose atomising and delivery device
EP0676963A4 (en)	1999-06-30	PHARMACEUTICAL COMPOSITIONS BASED ON HYALURONIC ACID AND UREA AND THEIR USE.
ZA978383B (en)	1998-03-24	Pharmaceutical compositions comprising amisulpride and therapeutic applications thereof.
AU8068294A (en)	1995-05-23	Gas pressurized liquid delivery system
ES2064244A1 (es)	1995-01-16	Composiciones de aerosol presurizadas.
WO2001045768A3 (en)	2002-01-10	Refillable device with counting means
AU6096396A (en)	1996-12-24	N,n-disulfonylated aminobenzene carboxylic acids and the use thereof as thrombin inhibitors
GR1001487B (el)	1994-02-28	Πεπιεσμένες συν?έσεις αεροζόλης.
IL109436A0 (en)	1994-07-31	Quinolyl-dihydropyridine esters, processes for their preparation, and their use in pharmaceutical compositions
HUT75711A (en)	1997-05-28	The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
HK1012672A (zh)	1999-08-06	用於氣霧劑發送裝置的封口
GB9315411D0 (en)	1993-09-08	Active agent delivery
IL124423A0 (en)	1998-12-06	Pharmaceutical composition comprising an active compound in a polymer
ZA927242B (en)	1993-03-22	Pressurised aerosol compositions.